| 2023-12-07 | -1.32 % |
|
| 2023-12-06 | -2.47 % |
|
| 2023-12-04 | -0.45 % |
|
| 2023-11-30 | -1.82 % |
|
| 2023-11-27 | -2.2 % |
|
| 2023-11-20 | +0.15 % |
|
| 2023-11-17 | +0.33 % |
|
| 2023-11-16 | +0.46 % |
|
| 2023-11-15 | +11.34 % |
|
| 2023-11-13 | -1.34 % |
|
| 2023-11-03 | +7.24 % |
|
| 2023-11-01 | -6.43 % |
|
| 2023-10-31 | -13.85 % |
|
| 2023-10-27 | +0.13 % |
- The article discusses the expectations for Novo Nordisk's third-quarter results and the potential impact on its stock price. Specifically, investors and analysts are looking for clarification on when supply constraints for Novo's weight-loss drug, Wegovy, in the United States will be lifted. The limited supply of Wegovy has led to soaring demand and has contributed to the significant increase in Novo's share price. The article suggests that the stock prices of Novo and its competitor, Eli Lilly, could be influenced by the resolution of these supply constraints.
- Catalent's stock (CTLT) went up by 0.13% following the increase in demand for obesity drugs, specifically Novo Nordisk's Wegovy and Eli Lilly's Mounjaro, which has boosted the value and market share of these companies in the healthcare industry. The growing obesity crisis has led to a surge in demand for weight-loss drugs, leading analysts to predict the market could be worth $100 billion by 2030. As a result, companies involved in the manufacturing and assembly of self-injection pens, such as Catalent, Thermo Fisher, and PCI Pharma Services, are experiencing significant growth and investment in their capacity to meet the demand.
|
| 2023-10-24 | +0.62 % |
|
| 2023-10-11 | +5.58 % |
|
| 2023-10-09 | +0.98 % |
|
| 2023-10-04 | -1.73 % |
|
| 2023-09-27 | +0.33 % |
|
| 2023-09-25 | +0.99 % |
- Catalent (CTLT) stock went up by 0.99% last night, likely driven by the positive outlook for the clinical trial supply and logistics market, which is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033, driven by the globalization of clinical trials, the shift towards personalized medicine, and the expansion into emerging markets.
- Carbon Revolution Ltd, a global manufacturer of carbon fiber wheels, has secured a Structured Equity Facility of up to US$110 million with two fund vehicles associated with Orion Infrastructure Capital, which will provide significant funding for the company's growth strategy; the increase in capital has likely caused the stock of Catalent, Carbon Revolution's parent company, to go up.
|
| 2023-09-20 | +1.54 % |
|
| 2023-09-18 | -4.01 % |
|
| 2023-09-15 | -1.03 % |
|
| 2023-09-14 | +1.74 % |
|
| 2023-09-13 | +1.1 % |
|
| 2023-09-11 | +1.11 % |
|
| 2023-09-07 | -1.49 % |
|
| 2023-09-05 | -0.26 % |
|
| 2023-09-01 | +0.46 % |
|
| 2023-08-31 | +2.02 % |
|
| 2023-08-30 | +2.45 % |
|
| 2023-08-29 | +4.75 % |
|
| 2023-08-28 | +1.67 % |
|
| 2023-08-25 | +0.65 % |
|
| 2023-08-24 | -1.68 % |
|
| 2023-08-23 | +2.14 % |
|
| 2023-08-22 | -2.18 % |
|
| 2023-08-21 | +2.34 % |
|
| 2023-08-14 | -1.52 % |
|
| 2023-08-11 | -0.73 % |
|
| 2023-08-08 | +4.28 % |
|
| 2023-08-01 | -4.14 % |
|
| 2023-07-28 | +1.13 % |
|
| 2023-07-25 | +0.54 % |
|
| 2023-07-20 | +2.72 % |
|
| 2023-07-12 | +1.78 % |
|
| 2023-07-10 | +1.99 % |
|
| 2023-06-30 | +0.74 % |
|
| 2023-06-28 | -3.33 % |
|
| 2023-06-27 | -4.79 % |
|
| 2023-06-22 | +1.66 % |
|
| 2023-06-20 | +0.34 % |
|
| 2023-06-16 | +1.19 % |
|
| 2023-06-15 | +3.56 % |
|
| 2023-06-14 | -4.01 % |
|
| 2023-06-13 | +2.5 % |
|
| 2023-06-12 | +10.23 % |
|
| 2023-06-09 | -0.49 % |
|
